应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02592 拨康视云-B
已收盘 02-02 16:08:06
2.390
-0.060
-2.45%
最高
2.450
最低
2.320
成交量
130.05万
今开
2.420
昨收
2.450
日振幅
5.31%
总市值
20.32亿
流通市值
20.32亿
总股本
8.50亿
成交额
308.44万
换手率
0.15%
流通股本
8.50亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
拨康视云-B盘中异动 股价大跌5.31%
市场透视 · 13:29
拨康视云-B盘中异动 股价大跌5.31%
每日卖空追踪 | 拨康视云-B 01月29日卖空量成交1.15万股,卖空比例为2.12%
市场透视 · 01-29
每日卖空追踪 | 拨康视云-B 01月29日卖空量成交1.15万股,卖空比例为2.12%
拨康视云-B宣布Cbt-004二期临床试验结束会议圆满成功,并与FDA就三期临床推进路径达成一致
美股速递 · 01-27
拨康视云-B宣布Cbt-004二期临床试验结束会议圆满成功,并与FDA就三期临床推进路径达成一致
每日卖空追踪 | 拨康视云-B 01月27日卖空量成交2500股,卖空比例为0.48%
市场透视 · 01-27
每日卖空追踪 | 拨康视云-B 01月27日卖空量成交2500股,卖空比例为0.48%
每日卖空追踪 | 拨康视云-B 01月23日卖空量成交2.7万股,卖空比例为2.26%
市场透视 · 01-23
每日卖空追踪 | 拨康视云-B 01月23日卖空量成交2.7万股,卖空比例为2.26%
拨康视云-B01月23日主力净流出25.8万元 散户资金买入
市场透视 · 01-23
拨康视云-B01月23日主力净流出25.8万元 散户资金买入
每日卖空追踪 | 拨康视云-B 01月21日卖空量成交8.35万股,卖空比例为7.67%
市场透视 · 01-21
每日卖空追踪 | 拨康视云-B 01月21日卖空量成交8.35万股,卖空比例为7.67%
每日卖空追踪 | 拨康视云-B 01月20日卖空量成交30.1万股,卖空比例为3.93%
市场透视 · 01-20
每日卖空追踪 | 拨康视云-B 01月20日卖空量成交30.1万股,卖空比例为3.93%
拨康视云-B盘中异动 早盘快速下跌5.41%
市场透视 · 01-20
拨康视云-B盘中异动 早盘快速下跌5.41%
拨康视云-B根据首次公开发售后股权激励计划授出合共800万份受限制股份单位
新浪港股 · 01-18
拨康视云-B根据首次公开发售后股权激励计划授出合共800万份受限制股份单位
拨康视云-B(02592)已根据和解协议的条款及条件,向Cedar Wealth悉数支付和解款项
智通财经 · 01-15
拨康视云-B(02592)已根据和解协议的条款及条件,向Cedar Wealth悉数支付和解款项
每日卖空追踪 | 拨康视云-B 01月15日卖空量成交14.05万股,卖空比例为15.61%
市场透视 · 01-15
每日卖空追踪 | 拨康视云-B 01月15日卖空量成交14.05万股,卖空比例为15.61%
每日卖空追踪 | 拨康视云-B 01月12日卖空量成交8.35万股,卖空比例为3.97%
市场透视 · 01-12
每日卖空追踪 | 拨康视云-B 01月12日卖空量成交8.35万股,卖空比例为3.97%
拨康视云-B盘中异动 早盘急速拉升5.12%
市场透视 · 01-12
拨康视云-B盘中异动 早盘急速拉升5.12%
拨康视云-B(02592):法院裁定对拨康视云广州在中国工商银行开设的银行账户实施司法保全至11月30日止
智通财经 · 01-07
拨康视云-B(02592):法院裁定对拨康视云广州在中国工商银行开设的银行账户实施司法保全至11月30日止
法院裁定拨康视云广州公司255万元账户冻结期延至2026年11月30日
美股速递 · 01-07
法院裁定拨康视云广州公司255万元账户冻结期延至2026年11月30日
每日卖空追踪 | 拨康视云-B 01月07日卖空量成交14.2万股,卖空比例为2.81%
市场透视 · 01-07
每日卖空追踪 | 拨康视云-B 01月07日卖空量成交14.2万股,卖空比例为2.81%
拨康视云-B盘中异动 下午盘股价大跌5.19%报3.650港元
市场透视 · 01-07
拨康视云-B盘中异动 下午盘股价大跌5.19%报3.650港元
拨康视云-B(02592)成功向药品审评中心提交CBT-009新药临床试验申请
智通财经 · 01-06
拨康视云-B(02592)成功向药品审评中心提交CBT-009新药临床试验申请
每日卖空追踪 | 拨康视云-B 01月05日卖空量成交10.45万股,卖空比例为1.04%
市场透视 · 01-05
每日卖空追踪 | 拨康视云-B 01月05日卖空量成交10.45万股,卖空比例为1.04%
加载更多
公司概况
公司名称:
拨康视云-B
所属市场:
SEHK
上市日期:
--
主营业务:
Cloudbreak Pharma Inc是一家临床阶段的眼科生物技术公司,从事开发各种治疗方法。该公司专注于眼科疗法的内部发现、开发和商业化。该公司拥有两款核心产品 CBT-001和CBT-009,均为自主研发。该公司的核心产品CBT-001用于治疗翼状胬肉(一种良性增生性眼表疾病),已在美国和中国启动III期多区域临床试验(MRCT)。该公司的核心产品CBT-009用于治疗青少年近视(5至19岁儿童和青少年的近视),已完成I/II期临床试验。该公司的其他候选药物处于相对早期的开发阶段,包括另外两种临床阶段候选药物,即CBT-006和CBT-004,以及四种临床前阶段候选药物,即CBT-007、CBT-199、CBT-145和CBT-011。
发行价格:
--
{"stockData":{"symbol":"02592","market":"HK","secType":"STK","nameCN":"拨康视云-B","latestPrice":2.39,"timestamp":1770019686006,"preClose":2.45,"halted":0,"volume":1300500,"delay":0,"changeRate":-0.024489795918367366,"floatShares":850000000,"shares":850000000,"eps":-0.208525,"marketStatus":"已收盘","change":-0.06,"latestTime":"02-02 16:08:06","open":2.42,"high":2.45,"low":2.32,"amount":3084380,"amplitude":0.053061,"askPrice":2.39,"askSize":6500,"bidPrice":2.38,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.386,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770082200000},"marketStatusCode":5,"adr":0,"listingDate":1751472000000,"exchange":"SEHK","adjPreClose":2.45,"openAndCloseTimeList":[[1769995800000,1770004800000],[1770008400000,1770019200000]],"volumeRatio":2.751216,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02592","defaultTab":"news","newsList":[{"id":"2608060855","title":"拨康视云-B盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608060855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608060855?lang=zh_cn&edition=full","pubTime":"2026-02-02 13:29","pubTimestamp":1770010145,"startTime":"0","endTime":"0","summary":"2026年02月02日下午盘13时29分,拨康视云-B股票出现波动,股价快速跳水5.31%。截至发稿,该股报2.320港元/股,成交量93.25万股,换手率0.11%,振幅5.31%。资金方面,该股资金流入28.1385万港元,流出127.222万港元。拨康视云-B股票所在的生物技术行业中,整体跌幅为4.16%。其相关个股中,中生北控生物科技、华康生物医学、中国抗体-B涨幅较大,振幅较大的相关个股有中慧生物-B、瑞博生物-B、百奥赛图-B,振幅分别为13.59%、13.44%、12.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020213290597a46d29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020213290597a46d29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2607006311","title":"每日卖空追踪 | 拨康视云-B 01月29日卖空量成交1.15万股,卖空比例为2.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607006311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607006311?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675433,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间01月29日,涨2.01%,卖空量成交1.15万股,较上一交易日减少23.33%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164044a463eb8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164044a463eb8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"1106546299","title":"拨康视云-B宣布Cbt-004二期临床试验结束会议圆满成功,并与FDA就三期临床推进路径达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1106546299","media":"美股速递","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106546299?lang=zh_cn&edition=full","pubTime":"2026-01-27 21:01","pubTimestamp":1769518877,"startTime":"0","endTime":"0","summary":"拨康视云-B(Cloudbreak Pharma)近日宣布,其核心候选药物Cbt-004的二期临床试验结束会议已圆满落幕。公司在此次关键会议上与美国食品药品监督管理局(FDA)进行了深入沟通,并就三期临床试验的后续推进路径达成重要共识。这一进展标志着Cbt-004的研发进程迈入新阶段,为后续临床开发奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2606757761","title":"每日卖空追踪 | 拨康视云-B 01月27日卖空量成交2500股,卖空比例为0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606757761","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606757761?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:30","pubTimestamp":1769502634,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间01月27日,跌3.42%,卖空量成交2500股,较上一交易日减少70.59%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164110a45b3ee8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164110a45b3ee8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2605845782","title":"每日卖空追踪 | 拨康视云-B 01月23日卖空量成交2.7万股,卖空比例为2.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605845782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605845782?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:30","pubTimestamp":1769157032,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间01月23日,跌2.65%,卖空量成交2.7万股,较上一交易日减少43.75%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163958a44da027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163958a44da027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2605284543","title":"拨康视云-B01月23日主力净流出25.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2605284543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605284543?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:15","pubTimestamp":1769156151,"startTime":"0","endTime":"0","summary":"01月23日, 拨康视云-B股价跌2.65%,报收2.57元,成交金额312.6万元,换手率0.14%,振幅5.68%,量比0.52。拨康视云-B今日主力资金净流出25.8万元,上一交易日主力净流出0万元。该股近5个交易日下跌17.89%,主力资金累计净流出362.2万元;近20日主力资金累计净流出2586.3万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123162241a44d8bd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123162241a44d8bd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2605043578","title":"每日卖空追踪 | 拨康视云-B 01月21日卖空量成交8.35万股,卖空比例为7.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605043578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605043578?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:30","pubTimestamp":1768984235,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间01月21日,涨0.38%,卖空量成交8.35万股,较上一交易日减少83.74%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165645a69b8551&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165645a69b8551&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2605120271","title":"每日卖空追踪 | 拨康视云-B 01月20日卖空量成交30.1万股,卖空比例为3.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605120271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605120271?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:30","pubTimestamp":1768897832,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间01月20日,跌15.61%,卖空量成交30.1万股,较上一交易日增加247.98%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120165330a4404a7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120165330a4404a7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2605411204","title":"拨康视云-B盘中异动 早盘快速下跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605411204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605411204?lang=zh_cn&edition=full","pubTime":"2026-01-20 09:52","pubTimestamp":1768873922,"startTime":"0","endTime":"0","summary":"2026年01月20日早盘09时52分,拨康视云-B股票出现波动,股价快速下跌5.41%。截至发稿,该股报2.970港元/股,成交量35.25万股,换手率0.04%,振幅5.41%。拨康视云-B股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,中生北控生物科技、华生物-B、北海康成-B涨幅较大,振幅较大的相关个股有中生北控生物科技、北海康成-B、华生物-B,振幅分别为10.57%、5.31%、5.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120095203953d6f5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120095203953d6f5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2604384978","title":"拨康视云-B根据首次公开发售后股权激励计划授出合共800万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2604384978","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604384978?lang=zh_cn&edition=full","pubTime":"2026-01-18 17:25","pubTimestamp":1768728300,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 拨康视云-B(02592)发布公告,于2026年1月16日,本公司根据首次公开发售后股权激励计划向两名承授人(包括本集团一名雇员;及一名服务供应商Whitcup Life Sciences LLC)合共授出800万份受限制股份单位,相当于本公司股本中每股面值0.0001美元的800万股普通股,惟须获承授人接纳,方可作实。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-18/doc-inhhtpht8691389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2603870607","title":"拨康视云-B(02592)已根据和解协议的条款及条件,向Cedar Wealth悉数支付和解款项","url":"https://stock-news.laohu8.com/highlight/detail?id=2603870607","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603870607?lang=zh_cn&edition=full","pubTime":"2026-01-15 20:32","pubTimestamp":1768480354,"startTime":"0","endTime":"0","summary":"智通财经APP讯,拨康视云-B 发布公告,有关Cedar Wealth针对本公司间接全资附属公司拨康视云广州提起法律程序。于本公告日期,本公司已根据和解协议的条款及条件,向Cedar Wealth悉数支付和解款项。据本公司中国法律顾问告知,预计自Cedar Wealth提交相关申请之日起,解除资产保全令及终止该等程序所需的法律及行政程序将耗时约六个星期方告完成。和解协议的条款及条件乃经订约方公平磋商后厘定,并属正常商业条款。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02592","BK1161"],"gpt_icon":1},{"id":"2603198982","title":"每日卖空追踪 | 拨康视云-B 01月15日卖空量成交14.05万股,卖空比例为15.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603198982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603198982?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:30","pubTimestamp":1768465832,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间01月15日,跌2.82%,卖空量成交14.05万股,较上一交易日减少33.73%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164243a71dca4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164243a71dca4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2603226544","title":"每日卖空追踪 | 拨康视云-B 01月12日卖空量成交8.35万股,卖空比例为3.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603226544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603226544?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:30","pubTimestamp":1768206630,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间01月12日,涨4.1%,卖空量成交8.35万股,较上一交易日减少89.07%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164937a4b9d4c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164937a4b9d4c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2602591150","title":"拨康视云-B盘中异动 早盘急速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602591150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602591150?lang=zh_cn&edition=full","pubTime":"2026-01-12 10:47","pubTimestamp":1768186078,"startTime":"0","endTime":"0","summary":"2026年01月12日早盘10时47分,拨康视云-B股票出现异动,股价大幅上涨5.12%。截至发稿,该股报3.080港元/股,成交量60.55万股,换手率0.07%,振幅4.78%。拨康视云-B股票所在的生物技术行业中,整体涨幅为0.49%。其相关个股中,百奥赛图-B、瑞博生物-B、北海康成-B涨幅较大,振幅较大的相关个股有北海康成-B、百奥赛图-B、华生物-B,振幅分别为16.59%、15.54%、12.84%。拨康视云-B公司简介:Cloudbreak Pharma Inc是一家临床阶段的眼科生物技术公司,从事开发各种治疗方法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112104758a4b8b1b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112104758a4b8b1b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2601680433","title":"拨康视云-B(02592):法院裁定对拨康视云广州在中国工商银行开设的银行账户实施司法保全至11月30日止","url":"https://stock-news.laohu8.com/highlight/detail?id=2601680433","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601680433?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:54","pubTimestamp":1767797698,"startTime":"0","endTime":"0","summary":"智通财经APP讯,拨康视云-B 发布公告,于2026年1月6日,拨康视云生物医药科技(广州)有限公司收到由广州市黄埔区人民法院签发日期为2025年12月24日的通知。法院应Cedar Wealth Management SPC的申请,透过法律程序作出裁定,对拨康视云广州在中国工商银行开设的银行账户实施司法保全至2026年11月30日止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161121","BK1161","02592"],"gpt_icon":1},{"id":"1195066117","title":"法院裁定拨康视云广州公司255万元账户冻结期延至2026年11月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=1195066117","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195066117?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:50","pubTimestamp":1767797404,"startTime":"0","endTime":"0","summary":"根据最新司法文件显示,拨康视云旗下广州子公司银行账户资金保全措施获法院裁定延期。该账户内255万元人民币资产将被持续冻结至2026年11月30日。\n此次账户保全令的延长,意味着相关司法程序可能进入更复杂的阶段。资本市场普遍关注此类企业资金流动受限情况对企业运营产生的潜在影响。\n专业法律人士指出,资产保全期限的延长通常与案件调查取证的复杂性相关。拨康视云作为创新药研发企业,此次账户冻结事项是否会影响其研发进度值得持续观察。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2601538465","title":"每日卖空追踪 | 拨康视云-B 01月07日卖空量成交14.2万股,卖空比例为2.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601538465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601538465?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:30","pubTimestamp":1767774632,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间01月07日,跌4.16%,卖空量成交14.2万股,较上一交易日减少49.29%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163454a4a6e720&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163454a4a6e720&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2601384656","title":"拨康视云-B盘中异动 下午盘股价大跌5.19%报3.650港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601384656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601384656?lang=zh_cn&edition=full","pubTime":"2026-01-07 15:16","pubTimestamp":1767770218,"startTime":"0","endTime":"0","summary":"2026年01月07日下午盘15时16分,拨康视云-B股票出现异动,股价大幅下挫5.19%。截至发稿,该股报3.650港元/股,成交量443.65万股,换手率0.52%,振幅8.31%。资金方面,该股资金流入444.802万港元,流出1196.29万港元。拨康视云-B股票所在的生物技术行业中,整体涨幅为4.89%。其相关个股中,荣昌生物、中国抗体-B、轩竹生物-B涨幅较大,振幅较大的相关个股有轩竹生物-B、中国抗体-B、盛禾生物-B,振幅分别为16.22%、16.20%、14.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107151658953c22d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107151658953c22d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2601700867","title":"拨康视云-B(02592)成功向药品审评中心提交CBT-009新药临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2601700867","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601700867?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:41","pubTimestamp":1767688918,"startTime":"0","endTime":"0","summary":"CBT-009是一种由本集团独立开发的新型、非水性阿托品眼用制剂,用于治疗5至19岁儿童及青少年的青少年近视。与现有水性阿托品滴眼液相比,CBT-009显著提升制剂稳定性,可在室温下长期储存且无需添加防腐剂,大幅改善患者用药依从性与使用体验。本公司认为,成功向药审中心提交新药临床试验申请,标志着CBT-009在中国临床开发的重要里程碑,为集团在该重要市场推进第三期临床试验奠定坚实基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389297.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CBT","BK1161","BK4090","02592"],"gpt_icon":0},{"id":"2601718884","title":"每日卖空追踪 | 拨康视云-B 01月05日卖空量成交10.45万股,卖空比例为1.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601718884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601718884?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:30","pubTimestamp":1767601831,"startTime":"0","endTime":"0","summary":"拨康视云-B北京时间01月05日,跌19.07%,卖空量成交10.45万股,较上一交易日减少78.09%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163657a49e2af9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163657a49e2af9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://cloudbreakpharma.com","stockEarnings":[{"period":"1week","weight":-0.0467},{"period":"1month","weight":-0.5288},{"period":"3month","weight":-0.4798},{"period":"6month","weight":-0.5196},{"period":"1year","weight":-0.7574},{"period":"ytd","weight":-0.5288}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0685},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1175},{"period":"1year","weight":0.3541},{"period":"ytd","weight":0.0685}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Cloudbreak Pharma Inc是一家临床阶段的眼科生物技术公司,从事开发各种治疗方法。该公司专注于眼科疗法的内部发现、开发和商业化。该公司拥有两款核心产品 CBT-001和CBT-009,均为自主研发。该公司的核心产品CBT-001用于治疗翼状胬肉(一种良性增生性眼表疾病),已在美国和中国启动III期多区域临床试验(MRCT)。该公司的核心产品CBT-009用于治疗青少年近视(5至19岁儿童和青少年的近视),已完成I/II期临床试验。该公司的其他候选药物处于相对早期的开发阶段,包括另外两种临床阶段候选药物,即CBT-006和CBT-004,以及四种临床前阶段候选药物,即CBT-007、CBT-199、CBT-145和CBT-011。","exchange":"SEHK","name":"拨康视云-B","nameEN":"CLOUDBREAK-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"拨康视云-B(02592)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供拨康视云-B(02592)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"拨康视云-B,02592,拨康视云-B股票,拨康视云-B股票老虎,拨康视云-B股票老虎国际,拨康视云-B行情,拨康视云-B股票行情,拨康视云-B股价,拨康视云-B股市,拨康视云-B股票价格,拨康视云-B股票交易,拨康视云-B股票购买,拨康视云-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"拨康视云-B(02592)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供拨康视云-B(02592)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}